TGA / PMDA / NMPA · Asia-Pacific
solutions — TGA / PMDA / NMPA regulatory status
solutions (NULL) regulatory status in the Asia-Pacific is tracked from public TGA / PMDA / NMPA records and cross-linked clinical and patent datasets on NovaPharmaNews. Current status: TGA approved.
Status snapshot
- Status
- TGA approved
- Brand
- NULL
- Structured fields
- 5
Regional decision snapshot — TGA: approved.
Linked evidence on this spoke: 2 published clinical programs and 12 related patent records. Use the tables below for NCT identifiers, phases, and exclusivity dates; verify against primary sources before BD or medical decisions.
Regulatory timeline
| Regulator | Region | Status | Date | Source |
|---|---|---|---|---|
| TGA | Australia | approved | — | Evidence |
Linked clinical programs
| Program | Phase | Sponsor | NCT |
|---|---|---|---|
| CARDIOPLEGIA SOLUTIONS | Approved | George Institute for | 2023-505855-32-01 |
| Shared Solutions® plus MS Center v. Shared Solutions® | Approved | Teva Pharma | NCT00240006 |
Related patents
| Number | Title | Jurisdiction |
|---|---|---|
| 12023410 | Micro/nanobubble solutions for tissue preservation and generation thereof | US |
| 11872244 | Thixotropic oxidized cellulose solutions and medical applications thereof | US |
| 11433038 | High concentration medicant solutions for treating neurological disorders | US |
| 2020353106 | Stable, concentrated radionuclide complex solutions | US |
| 2020030466 | Stable, concentrated radionuclide complex solutions | US |
| 2020030465 | Stable, concentrated radionuclide complex solutions | US |
| 10413566 | Thixotropic oxidized cellulose solutions and medical applications thereof | US |
| 10086114 | Antimicrobial solutions with enhanced stability | US |
| 9844530 | Ophthalmic solutions for glaucoma and conjunctivitis treatment | US |
| 9814695 | Ophthalmic solutions for glaucoma and conjunctivitis treatment | US |
| 9700509 | Solutions of lipophilic substances, especially medicinal solutions | US |
| 9637597 | DOPA-melanin formation in high ionic strength solutions | US |
Related hubs
FAQ
What is the TGA / PMDA / NMPA approval status of solutions?
solutions currently shows TGA approved in our Asia-Pacific regulatory index. Confirm on the official TGA / PMDA / NMPA label or EPAR before clinical or commercial use.
Where does NovaPharmaNews get solutions regulatory data?
Status fields are joined from public sources (openFDA / EMA / regional agencies), ClinicalTrials.gov-linked programs, and patent registries. See /about/data-sources for attribution.
How many clinical programs are linked to solutions?
This spoke lists 2 published programs associated with solutions in our pipeline index.